Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of Book Value per share over the past 5 years, which is 8.08 instead of 15 in this case.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
96.01
/
93.00
=
1.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Peter Lynch Fair Value Related Terms
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Peter Lynch Fair Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Peter Lynch Fair Value Chart
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Annual Data
BSP:HUSC11 vs WELL, VTR, OHI: Peter Lynch Fair Value Comparison
For the REIT - Healthcare Facilities subindustry, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Price-to-Peter-Lynch-Fair-Value vs REITs Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM Book Value Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data is the latest quarter data. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of R$93.00 mean?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a Peter Lynch Fair Value of R$93.00 as of Aug. 14, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. This is 9488% above median its historical median of 0.97. Over the past decade, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Peter Lynch Fair Value has ranged from 0.38 to 1.03.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Peter Lynch Fair Value too high?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current Peter Lynch Fair Value of R$93.00 is 9488% above median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 1.03. Overall, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Peter Lynch Fair Value compare to WELL and VTR?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Peter Lynch Fair Value of R$93.00 can be compared against companies in the REITs industry. The industry median Peter Lynch Fair Value is 1.14. Historically, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's own Peter Lynch Fair Value has ranged from 0.38 to 1.03 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a REITs company?
The median Peter Lynch Fair Value among REITs companies is 1.14, based on 164 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. For the REITs industry, the median Peter Lynch Fair Value is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current Peter Lynch Fair Value is R$93.00, which is 9488% above median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock overvalued right now?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a current Peter Lynch Fair Value of R$93.00. The stock's GF Value™ is R$33.29, compared to a current price of R$96.01 — trading 188.4% above its estimated fair value. The current Peter Lynch Fair Value is R$93.00, which is 9488% above median its 10-year median of 0.97. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11), the current Peter Lynch Fair Value is R$93.00 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Overvalued in 2026?
Based on GuruFocus' analysis, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock appears to be overvalued.
The current stock price of R$96.01 is trading 188.4% above its estimated GF Value™ of R$33.29.
Key valuation signals for BSP:HUSC11:
Peter Lynch Fair Value: R$93.00 (9488% above median its 10-year median of 0.97)
GF Value™: R$33.29 vs. price of R$96.01 (188.4% above fair value)
No single metric tells the full story. See the BSP:HUSC11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:HUSC11 has been successfully added to your 
